Miles Fisher & John J. McMurray 
Diabetic Cardiology 

With cardiovascular disease becoming the most common cause of death
in people with diabetes, interest in the assessment and treatment
of heart disease in these patients has been reawakened. This
book examines developing topics from a largely cardiological
perspective, covering both pharmacological and
non-pharmacological interventions.

The DIGAMI study on the use of intravenous insulin infusion at
the time of myocardial infarction (MI) has stimulated a large
number of discussion papers on the best treatment of MI in the
diabetic patient. The UKPDS has shown that treatment of Type 2
diabetes does not reduce cardiovascular end-points significantly,
but that aggressive treatment of blood pressure can do so. In
addition, sub-group analysis from several large cardiovascular
trials has shown that treatment with statins, anti-platelet
therapy, ACE inhibitors and other drugs will also reduce
cardiovascular events in people with diabetes.

About the author

Miles Fisher, Consultant Physician, Glasgow Royal Infirmary

John Mc Murray, Professor of Medical Cardiology, British
Heart Foundation Cardiovascular Research Centre, University of
Glasgow and Honorary Consultant Cardiologist, Western Infirmary,
Glasgow